NASDAQ:ANPC

Anpac Bio-Medical Science Stock Forecast, Price & News

$3.21

-0.15 (-4.47 %)

(As of 10/30/2020 12:00 AM ET)

Add

Compare

Today's Range

$3.18

Now: $3.21▼

$3.39

50-Day Range

$3.36

MA: $4.00▼

$5.20

52-Week Range

$3.15

Now: $3.21▼

$12.18

Volume18,289 shs

Average Volume32,419 shs

Market Capitalization$35.92 million

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Anpac Bio-Medical Science Co., Ltd., a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests to corporations and life insurance companies in the People's Republic of China and the United States. It also manufactures cancer differentiation analysis devices; and offers physical checkup package services. The company was founded in 2010 and is headquartered in Lishui, the People's Republic of China.

Beat the Market (BTM) Rank^™

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Anpac Bio-Medical Science.

2.9 Community Rank

Outperform Votes
Anpac Bio-Medical Science has received 7 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Anpac Bio-Medical Science has received 5 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Anpac Bio-Medical Science has received 58.33% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Anpac Bio-Medical Science and other stocks. Vote “Outperform” if you believe ANPC will outperform the S&P 500 over the long term. Vote “Underperform” if you believe ANPC will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Anpac Bio-Medical Science does not currently pay a dividend.
Dividend Growth
Anpac Bio-Medical Science does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Anpac Bio-Medical Science insiders have not sold or bought any company stock.
Percentage Held by Institutions
Only 0.03% of the stock of Anpac Bio-Medical Science is held by institutions.

0.6 Earnings and Valuation

Earnings Growth
Earnings for Anpac Bio-Medical Science are expected to grow in the coming year, from ($1.03) to ($0.55) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Anpac Bio-Medical Science is -1.98, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Anpac Bio-Medical Science is -1.98, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Overall Beat the Market Rank^™

0.71 out of 5 stars

Industry, Sector and Symbol

Stock Exchange NASDAQ

Industry Medical laboratories

Sub-IndustryN/A

SectorMedical

Current SymbolNASDAQ:ANPC

Previous Symbol

CUSIPN/A

CIKN/A

Webwww.anpacbio.com

Phone86-57-8205-1666

EmployeesN/A

Debt

Debt-to-Equity RatioN/A

Current Ratio0.94

Quick Ratio0.93

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual Sales$1.56 million

Price / Sales23.03

Cash FlowN/A

Price / Cash FlowN/A

Book Value($1.37) per share

Price / Book-2.34

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Miscellaneous

Outstanding Shares11,200,000

Market Cap$35.92 million

Next Earnings DateN/A

OptionableNot Optionable

$3.21

-0.15 (-4.47 %)

(As of 10/30/2020 12:00 AM ET)

30 days | 90 days | 365 days | Advanced Chart

Receive ANPC News and Ratings via Email

Sign-up to receive the latest news and ratings for ANPC and its competitors with MarketBeat's FREE daily newsletter.

Anpac Bio-Medical Science (NASDAQ:ANPC) Frequently Asked Questions

How has Anpac Bio-Medical Science's stock been impacted by Coronavirus?

Anpac Bio-Medical Science's stock was trading at $8.50 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, ANPC stock has decreased by 62.3% and is now trading at $3.2075.
View which stocks have been most impacted by COVID-19.

Who are some of Anpac Bio-Medical Science's key competitors?

Some companies that are related to Anpac Bio-Medical Science include Enzo Biochem (ENZ), Miragen Therapeutics (MGEN), Biocept (BIOC), Celcuity (CELC), OpGen (OPGN), Psychemedics (PMD), Zicix (ZICX), American Shared Hospital Services (AMS), Avant Diagnostics (AVDX), American Shared Hospital Services (AMS), CBA Florida (CBAI), Cancer Genetics (CGIX), PotNetwork (POTN), First Choice Healthcare Solutions (FCHS) and Aeon Global Health (AGHC).
View all competitors.

What other stocks do shareholders of Anpac Bio-Medical Science own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Anpac Bio-Medical Science investors own include Applied Genetic Technologies (AGTC), Aurora Cannabis (ACB), Adobe (ADBE), Advaxis (ADXS), Aptose Biosciences (APTO), Arcturus Therapeutics (ARCT), Ardelyx (ARDX), Ascendis Pharma A/S (ASND), Athenex (ATNX) and Aurinia Pharmaceuticals (AUPH).

When did Anpac Bio-Medical Science IPO?

(ANPC) raised $22 million in an initial public offering on the week of January 13th 2020. The company issued 1,700,000 shares at a price of $12.00-$14.00 per share. WestPark Capital and Univest Securities served as the underwriters for the IPO.

What is Anpac Bio-Medical Science's stock symbol?

Anpac Bio-Medical Science trades on the NASDAQ under the ticker symbol "ANPC."

How do I buy shares of Anpac Bio-Medical Science?

Shares of ANPC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Anpac Bio-Medical Science's stock price today?

One share of ANPC stock can currently be purchased for approximately $3.21.

How big of a company is Anpac Bio-Medical Science?

Anpac Bio-Medical Science has a market capitalization of $35.92 million and generates $1.56 million in revenue each year. The company earns $-14,520,000.00 in net income (profit) each year or ($1.62) on an earnings per share basis.

What is Anpac Bio-Medical Science's official website?

The official website for Anpac Bio-Medical Science is www.anpacbio.com.

How can I contact Anpac Bio-Medical Science?

Anpac Bio-Medical Science's mailing address is 801 BIXING STREET BIHU COUNTY ZHEJIANG PROVINCE, LISHUI F4, 323006. The company can be reached via phone at 86-57-8205-1666 or via email at [email protected]

This page was last updated on 10/31/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Get Started with MarketBeat

	Read Your Daily Newsletter
	Check Out My MarketBeat
	Watch Our Tutorial Videos
	Add a Stock to Your Watchlist
	Set Up an Instant Alert
	View a Company's Profile Page
	View Our Financial Calendars
	View Today's Analyst Ratings